You are here

Amarin

Amarin vs. the Generics: Who Will Win?

Motley Fool

Sun, 11/22/20 - 11:55 pm

AHA: Amarin's Vascepa cuts cardiovascular events in patients with coronary artery grafts

Fierce Pharma

Mon, 11/16/20 - 10:33 pm

Amarin loses patent appeal and their brief grip on a cardiovascular, fish oil empire

Endpoints

Fri, 09/4/20 - 12:04 am

Amarin Patent Appeal Is a Coin Toss With Billions on the Line

Yahoo/Bloomberg

Wed, 09/2/20 - 11:07 am

ESC: Amarin's Vascepa reduces patients' arterial plaque after 18 months of treatment

Fierce Pharma

Sun, 08/30/20 - 11:26 pm

arterial plaque

Amarin spurns would-be marketing partners to launch Vascepa in Europe on its own

Fierce Pharma

Tue, 08/4/20 - 12:38 pm

Here's Why Amarin Tumbled 67.7% in the First Half of 2020

Motley Fool

Thu, 07/9/20 - 12:02 am

A new hope for Amarin? Vascepa generic settlement leaves analysts split on patent appeal success

Fierce Pharma

Wed, 06/17/20 - 10:20 pm

FDA approves the first generic for Amarin's Vascepa — but is a launch imminent?

Endpoints

Fri, 05/22/20 - 11:03 am

Can Amarin's Stock Recover From Its 70% Implosion?

Motley Fool

Sat, 04/18/20 - 11:24 pm

Are Amarin's Blockbuster Dreams Over?

Motley Fool

Sun, 04/5/20 - 02:37 pm

Disaster at Amarin: Stock plummets 70% after Vascepa patent challenge loss

Fierce Pharma

Mon, 03/30/20 - 08:20 pm

Drug makers grounding salespeople as coronavirus impact on business spreads

Stat

Mon, 03/16/20 - 10:45 am

Why Amarin Stock Plunged in February

Motley Fool

Fri, 03/6/20 - 10:38 am

Amarin aims for Vascepa boom with doubled sales force nearly in place

Fierce Pharma

Wed, 02/26/20 - 11:31 pm

Amarin: Is It Time to Test the Waters?

Motley Fool

Wed, 02/26/20 - 10:41 am

With Vascepa nod in the bag, Amarin rolls CV risk campaign targeting passé prescription meds

Fierce Pharma

Thu, 01/23/20 - 12:33 pm

JPM: With Vascepa's U.S. expansion rolling, Amarin CEO holds off partner offers in EU

Fierce Pharma

Thu, 01/16/20 - 11:06 pm

AstraZeneca's Epanova flunks key heart risk trial, giving Amarin's rival Vascepa a leg up

Fierce Pharma

Mon, 01/13/20 - 11:01 am

clinical trials

Fish oil pill for NASH? Dutch biotech scores $40M injection to make a mark in the bustling field

Endpoints

Wed, 01/8/20 - 10:41 am

NorthSea Therapeutics

Pages